4.8 Article

Priority actions for the non-communicable disease crisis

期刊

LANCET
卷 377, 期 9775, 页码 1438-1447

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(11)60393-0

关键词

-

资金

  1. Wellcome Trust
  2. Family Health International
  3. 19 Inter-American Development Bank
  4. Bayer
  5. Allergan
  6. Syngis
  7. Servier
  8. 22 Photothera
  9. Boehringer-Ingelheim
  10. Pfizer
  11. Wiley
  12. Sanofi-Aventis
  13. Varian Medical Systems
  14. Roche
  15. Boehringer Ingelheim
  16. Novartis
  17. Slender
  18. 23 Merck
  19. Eli Lilly
  20. Heng Rui
  21. Irmet
  22. National Heart Forum

向作者/读者索取更多资源

The UN High-Level Meeting on Non-Communicable Diseases (NCDs) in September, 2011, is an unprecedented opportunity to create a sustained global movement against premature death and preventable morbidity and disability from NCDs, mainly heart disease, stroke, cancer, diabetes, and chronic respiratory disease. The increasing global crisis in NCDs is a barrier to development goals including poverty reduction, health equity, economic stability, and human security. The Lancet NCD Action Group and the NCD Alliance propose five overarching priority actions for the response to the crisis leadership, prevention, treatment, international cooperation, and monitoring and accountability and the delivery of five priority interventions tobacco control, salt reduction, improved diets and physical activity, reduction in hazardous alcohol intake, and essential drugs and technologies. The priority interventions were chosen for their health effects, cost-effectiveness, low costs of implementation, and political and financial feasibility. The most urgent and immediate priority is tobacco control. We propose as a goal for 2040, a world essentially free from tobacco where less than 5% of people use tobacco. Implementation of the priority interventions, at an estimated global commitment of about US$9 billion per year, will bring enormous benefits to social and economic development and to the health sector. If widely adopted, these interventions will achieve the global goal of reducing NCD death rates by 2% per year, averting tens of millions of premature deaths in this decade.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据